Concepedia

Pedro A. Torres‐Saavedra

PA

16

Publications

883

Citations

12

H-Index

2014

Active since

Affiliations

NRG Oncology(Current)

American College of Radiology

Stanford University

Moffitt Cancer Center

The University of Texas MD Anderson Cancer Center

Pedro A. Torres‐Saavedra is an author at NRG Oncology specializing in oncology, medicine, and radiation oncology.

ORCID

Top concepts

Publications per year

2014–2024

16

Publications

16

Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)

Sue S. Yom, Pedro A. Torres‐Saavedra, Jimmy J. Caudell et al. · Journal of Clinical Oncology · 2021 · 344 citations · Full text

Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis

Claire Petit, Benjamin Lacas, Jean‐Pierre Pignon et al. · The Lancet Oncology · 2021 · 100 citations · Full text

, , +6

Drugs and Alcohol: Their Relative Crash Risk

Eduardo Romano, Pedro A. Torres‐Saavedra, Robert B. Voas et al. · Journal of Studies on Alcohol and Drugs · 2014 · 90 citations · Full text

NRG-HN002: A Randomized Phase II Trial for Patients With p16-Positive, Non-Smoking-Associated, Locoregionally Advanced Oropharyngeal Cancer

Sue S. Yom, Pedro A. Torres‐Saavedra, Jimmy J. Caudell et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 87 citations

, , +4

Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial

Loren K. Mell, Pedro A. Torres‐Saavedra, Stuart J. Wong et al. · The Lancet Oncology · 2024 · 44 citations · Full text

Rows per page

1–5 of 16